Exopharm Ltd. (AU:EX1) has released an update.
Exopharm Limited has announced the issue of 310,419,560 unlisted options at $0.027 each, which are set to expire three years from their reinstatement date of May 1, 2024. These securities are not intended to be quoted on the ASX, aligning with a transaction previously communicated to the market.
For further insights into AU:EX1 stock, check out TipRanks’ Stock Analysis page.
